Clemente J Britto

7PUBLICATIONS
23CO-AUTHORS
Medical infection agents (incl. prions)Separation technologiesNeonatologyPredictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2025
Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis.

Benjamin K Chan, Gail L Stanley, Kaitlyn E Kortright

|Apr 08, 2025
CFTR function in alveolar type 1 cells drives lung liquid secretion and host defense.

Sayahi Suthakaran, Sonya Homami, Deebly Chavez

|Mar 16, 2022
Charting a New Path: A Single-Cell Atlas of Porcine Cystic Fibrosis Airways at Birth.

Clemente J Britto

|Jan 26, 2022
Characterization of the COPD alveolar niche using single-cell RNA sequencing.

Maor Sauler, John E McDonough, Taylor S Adams

|May 07, 2021
SPLUNC1: a novel marker of cystic fibrosis exacerbations.

Sara Khanal, Megan Webster, Naiqian Niu

|Jul 05, 2019
CFTR-PTEN-dependent mitochondrial metabolic dysfunction promotes <i>Pseudomonas aeruginosa</i> airway infection.

Sebastián A Riquelme, Carmen Lozano, Ahmed M Moustafa

Pageof 2